SoFi Technologies closed Friday at $18.06, down nearly 6% on the day and 4.5% on the week — reversing course after the previous note described a stock that had just reclaimed $19 and shaken off its most bearish positioning in months.
The reversal is worth framing against what changed. The August 28 note documented a clean setup: options hedges unwound, short sellers cutting, price momentum constructive. Since then the tape has deteriorated. Friday's 5.8% single-session drop pulled the stock back below $18, erasing much of the August gain. The one-month picture still shows a 7.9% advance from the late-July lows, but the weekly loss suggests the move has stalled. Peer context reinforces the picture — UPST fell 4.5% on the day and 4% on the week, while HAPN dropped 3% and 2.9% respectively. DAVE was a notable exception, rising 6.7% on the week, but the broader fintech group sold off in concert with SoFi rather than diverging from it. This looks like sector-level pressure, not a company-specific unwind.
Short interest is telling a more nuanced story than the price action alone suggests. The headline direction remains constructive: shorts trimmed 7.2% on the week to 14% of the free float, roughly 169 million shares — continuing a gradual retreat that has taken the position from above 15% in mid-August. The borrow market is notably relaxed. Cost to borrow runs at 0.46%, barely changed over the week and well below levels that would indicate stress. Availability is at 171%, meaning for every share currently borrowed, there are nearly 1.7 more available to lend — a comfortable buffer that is well above the 52-week tightest reading of 79.6%. The ORTEX short score ticked down to 62.3 from 65.4 earlier in the week, consistent with the shorts-in-retreat theme. Positioning, in other words, looks like managed reduction rather than panic covering or fresh aggression — the lenders have inventory, and the shorts are not being squeezed.
Options traders remain calm. The put/call ratio closed at 0.41, marginally below its 20-day average of 0.42 and statistically indistinguishable from neutral — a z-score of -0.37. The 52-week range on the PCR runs from 0.37 to 0.68, placing the current reading near the lower (more call-heavy) end of the band. There is no defensive signal in the derivatives market, which stands in contrast to the price drop — options traders are not loading up on downside protection into the weakness.
The Street picture is mixed, with recent analyst moves pulling in opposite directions. Piper Sandler initiated coverage earlier this month with an Overweight rating and a $22 target, adding a fresh bull to the register. Against that, Morgan Stanley maintained its Underweight with a $15 target after trimming the figure by a dollar at the end of July — the most bearish marker on the board and the clearest expression of the bear case around credit risk and lending-cycle exposure. Bulls congregate around the bank charter, Galileo's embedded finance infrastructure, and a P/E that has drifted up to roughly 25x on the back of improved profitability, still reasonable for a fintech growing into its margin structure. The mean analyst target of $20.03 implies roughly 11% upside from Friday's close, while the analyst recommendation differential ranks in the 95th percentile of the ORTEX universe — suggesting the consensus tilt is unusually bullish relative to history. The P/B multiple at 1.99x has risen 0.39 points over the past month, reflecting the stock's better year-on-year performance even as it pulls back this week.
Institutional flows add a layer of interest. Goldman Sachs Asset Management added nearly 9.6 million shares in the most recently reported quarter, bringing its position to 15.4 million shares. BlackRock and Vanguard both added modestly as well. Against that, D.E. Shaw cut its position by 28 million shares — the largest single-holder reduction in the table. CEO Anthony Noto holds 11.96 million shares with a small addition reported in June, providing alignment at the top. The insider ledger shows routine executive selling in August — the Chief Risk Officer and an EVP each sold modest amounts near $18 — but the 90-day net insider position is actually a small positive at approximately 500,000 shares, driven by award grants.
The next earnings event is flagged for October 26. The most recent print in late July produced a muted one-day reaction of -1.6%, but the stock recovered sharply over the following five sessions, gaining 9%. The question heading into Q3 results will be whether the margin trajectory that underpins the current 25x PE multiple holds in a period where the consumer finance sector is under visible pressure — the setup into that print will be worth watching for any renewed shift in options positioning or short-seller behavior.
See the live data behind this article on ORTEX.
Open SOFI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
